TOKYO -- Japanese Prime Minister Shinzo Abe's push to speed the authorization of the flu drug Avigan as a coronavirus treatment has been slowed as the process gets caught up in bureaucratic red tape.
As early as February, Abe's right-hand man, Chief Cabinet Secretary Yoshihide Suga, directed the Ministry of Health, Labor and Welfare to work quickly toward official approval of the medication developed by a Fujifilm Holdings subsidiary.
_2048x1152%2520(1).jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
